BR112019009131A2 - vacina contra o parvovírus suíno, o vírus da síndrome respiratória e reprodutiva dos suínos e métodos de produção das mesmas - Google Patents
vacina contra o parvovírus suíno, o vírus da síndrome respiratória e reprodutiva dos suínos e métodos de produção das mesmasInfo
- Publication number
- BR112019009131A2 BR112019009131A2 BR112019009131A BR112019009131A BR112019009131A2 BR 112019009131 A2 BR112019009131 A2 BR 112019009131A2 BR 112019009131 A BR112019009131 A BR 112019009131A BR 112019009131 A BR112019009131 A BR 112019009131A BR 112019009131 A2 BR112019009131 A2 BR 112019009131A2
- Authority
- BR
- Brazil
- Prior art keywords
- swine
- syndrome virus
- respiratory
- reproductive syndrome
- porcine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/23—Parvoviridae, e.g. feline panleukopenia virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14311—Parvovirus, e.g. minute virus of mice
- C12N2750/14322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/10011—Arteriviridae
- C12N2770/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Abstract
a presente invenção refere-se a uma vacina de parvovírus suíno e de vírus da síndrome respiratória e reprodutiva dos suínos para proteger um indivíduo, de preferência suíno, contra doenças associadas com o parvovírus suíno e o vírus da síndrome respiratória e reprodutiva dos suínos. a presente invenção refere-se ainda aos métodos de produção de composições imunogênicas, bem como a tais composições imunogênicas que apresentam atividade virucida reduzida.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP16197089 | 2016-11-03 | ||
PCT/EP2017/078020 WO2018083156A1 (en) | 2016-11-03 | 2017-11-02 | Vaccine against porcine parvovirus and porcine reproductive and respiratory syndrome virus and methods of production thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112019009131A2 true BR112019009131A2 (pt) | 2019-07-16 |
Family
ID=57223616
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112019009131A BR112019009131A2 (pt) | 2016-11-03 | 2017-11-02 | vacina contra o parvovírus suíno, o vírus da síndrome respiratória e reprodutiva dos suínos e métodos de produção das mesmas |
Country Status (22)
Country | Link |
---|---|
US (2) | US10660952B2 (pt) |
EP (1) | EP3534939B1 (pt) |
JP (2) | JP6941171B2 (pt) |
KR (1) | KR20190080921A (pt) |
CN (1) | CN109922825B (pt) |
AU (1) | AU2017353380A1 (pt) |
BR (1) | BR112019009131A2 (pt) |
CA (1) | CA3042584A1 (pt) |
CL (1) | CL2019001200A1 (pt) |
DK (1) | DK3534939T3 (pt) |
EA (1) | EA201991041A1 (pt) |
ES (1) | ES2942749T3 (pt) |
FI (1) | FI3534939T3 (pt) |
HU (1) | HUE061972T2 (pt) |
MX (2) | MX2019005136A (pt) |
MY (1) | MY191895A (pt) |
PH (1) | PH12019500989A1 (pt) |
PL (1) | PL3534939T3 (pt) |
PT (1) | PT3534939T (pt) |
RS (1) | RS64144B1 (pt) |
TW (1) | TWI788309B (pt) |
WO (1) | WO2018083156A1 (pt) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RS64144B1 (sr) | 2016-11-03 | 2023-05-31 | Boehringer Ingelheim Vetmedica Gmbh | Vakcina protiv svinjskog parvovirusa i virusa reproduktivnog i respiratornog sindroma svinja i postupci njegove proizvodnje |
MY191490A (en) | 2016-11-03 | 2022-06-28 | Boehringer Ingelheim Vetmedica Gmbh | Vaccine against porcine parvovirus |
MX2020010018A (es) * | 2018-03-26 | 2020-10-14 | Boehringer Ingelheim Animal Health Usa Inc | Metodo para producir una composicion inmunogenica. |
KR102117811B1 (ko) * | 2018-12-05 | 2020-06-02 | 대한민국(농림축산식품부 농림축산검역본부장) | 재조합 돼지파보바이러스 항원 단백질 및 이의 용도 |
US10973908B1 (en) | 2020-05-14 | 2021-04-13 | David Gordon Bermudes | Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine |
CN112521460A (zh) * | 2020-12-08 | 2021-03-19 | 嘉兴千纯生物科技有限公司 | 一种纯化重组猪细小病毒vp2蛋白的层析工艺 |
Family Cites Families (64)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US382425A (en) | 1888-05-08 | Brandt | ||
US2909462A (en) | 1955-12-08 | 1959-10-20 | Bristol Myers Co | Acrylic acid polymer laxative compositions |
US4394448A (en) | 1978-02-24 | 1983-07-19 | Szoka Jr Francis C | Method of inserting DNA into living cells |
US4769331A (en) | 1981-09-16 | 1988-09-06 | University Patents, Inc. | Recombinant methods and materials |
US4722848A (en) | 1982-12-08 | 1988-02-02 | Health Research, Incorporated | Method for immunizing animals with synthetically modified vaccinia virus |
US4603112A (en) | 1981-12-24 | 1986-07-29 | Health Research, Incorporated | Modified vaccinia virus |
US5174993A (en) | 1981-12-24 | 1992-12-29 | Health Research Inc. | Recombinant avipox virus and immunological use thereof |
US5505941A (en) | 1981-12-24 | 1996-04-09 | Health Research, Inc. | Recombinant avipox virus and method to induce an immune response |
US5833975A (en) | 1989-03-08 | 1998-11-10 | Virogenetics Corporation | Canarypox virus expressing cytokine and/or tumor-associated antigen DNA sequence |
US5364773A (en) | 1991-03-07 | 1994-11-15 | Virogenetics Corporation | Genetically engineered vaccine strain |
US4769330A (en) | 1981-12-24 | 1988-09-06 | Health Research, Incorporated | Modified vaccinia virus and methods for making and using the same |
US5338683A (en) | 1981-12-24 | 1994-08-16 | Health Research Incorporated | Vaccinia virus containing DNA sequences encoding herpesvirus glycoproteins |
EP0117767A1 (en) | 1983-01-07 | 1984-09-05 | Mgi Pharma, Inc. | Production of parvovirus subunit vaccines |
US4745051A (en) | 1983-05-27 | 1988-05-17 | The Texas A&M University System | Method for producing a recombinant baculovirus expression vector |
US4945050A (en) | 1984-11-13 | 1990-07-31 | Cornell Research Foundation, Inc. | Method for transporting substances into living cells and tissues and apparatus therefor |
JPH01503675A (ja) | 1986-09-08 | 1989-12-14 | アプライド・バイオテクノロジー・インコーポレーテツド | 中空ウイルスキヤプシドのワクチン |
IE872748L (en) | 1986-10-16 | 1988-04-16 | Arjomari Europ | Polypeptides derived from the evvelope gene of human¹immunodeficiency virus in recombinant baculovirus infected¹insect cells |
GB8717430D0 (en) | 1987-07-23 | 1987-08-26 | Celltech Ltd | Recombinant dna product |
WO1990001543A1 (fr) | 1988-07-29 | 1990-02-22 | Intracel Corporation | Procede d'expression genetique de proteines heterologues par des cellules transfectees in vivo |
CA2003300A1 (en) | 1988-11-21 | 1990-05-21 | Franklin Volvovitz | Skin test and test kit for aids |
CA2489769A1 (en) | 1989-03-21 | 1990-10-04 | Philip L. Felgner | Expression of exogenous polynucleotide sequences in a vertebrate |
US5703055A (en) | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
US5552143A (en) | 1989-03-24 | 1996-09-03 | The Wistar Institute Of Anatomy & Biology | Recombinant cytomegalovirus vaccine |
US5591439A (en) | 1989-03-24 | 1997-01-07 | The Wistar Institute Of Anatomy And Biology | Recombinant cytomegalovirus vaccine |
GB9001766D0 (en) | 1990-01-25 | 1990-03-28 | Univ Court Of The University O | Vaccines |
WO1992015672A1 (en) | 1991-03-07 | 1992-09-17 | Virogenetics Corporation | Genetically engineered vaccine strain |
US5997878A (en) | 1991-03-07 | 1999-12-07 | Connaught Laboratories | Recombinant poxvirus-cytomegalovirus, compositions and uses |
ES2026827A6 (es) | 1991-03-26 | 1992-05-01 | Ercros Sa | Procedimiento para la produccion de una vacuna subunidad contra el parvovirus porcino. |
US6042830A (en) | 1992-08-05 | 2000-03-28 | Boehringer Ingelheim Vetmedica, Inc. | Viral agent associated with mystery swine disease |
US5643578A (en) | 1992-03-23 | 1997-07-01 | University Of Massachusetts Medical Center | Immunization by inoculation of DNA transcription unit |
US5695766A (en) | 1992-10-30 | 1997-12-09 | Iowa State University Research Foundation | Highly virulent porcine reproductive and respiratory syndrome viruses which produce lesions in pigs and vaccines that protect pigs against said syndrome |
US5801029A (en) | 1993-02-16 | 1998-09-01 | Onyx Pharmaceuticals, Inc. | Cytopathic viruses for therapy and prophylaxis of neoplasia |
IL108915A0 (en) | 1993-03-18 | 1994-06-24 | Merck & Co Inc | Polynucleotide vaccine against influenza virus |
FR2711670B1 (fr) | 1993-10-22 | 1996-01-12 | Pasteur Institut | Vecteur nucléotidique, composition le contenant et vaccin pour l'immunisation à l'encontre d'une hépatite. |
ATE475668T1 (de) | 1994-01-27 | 2010-08-15 | Univ Massachusetts Medical | Immunisierung durch impfung von dns transkriptionseinheit |
DK0758397T3 (da) | 1994-04-29 | 2005-10-10 | Baxter Healthcare Sa | Rekombinante poxvira med fremmede polynucleotider i essentielle regioner |
CA2215162A1 (en) | 1995-03-23 | 1996-09-26 | Cantab Pharmaceuticals Research Limited | Vectors for gene delivery |
ES2102971B1 (es) | 1996-01-25 | 1998-03-01 | Hipra Lab Sa | Nueva cepa atenuada del virus causante del sindrome respiratorio y reproductivo porcino (prrs), las vacunas y medios de diagnostico obtenibles con la misma y los procedimientos para su obtencion. |
US6015663A (en) | 1996-03-01 | 2000-01-18 | The United States Of America As Represented By The Secretary Of Agriculture | Restriction enzyme screen for differentiating porcine reproductive and respiratory syndrome virus strains |
EP0979101B1 (en) | 1996-07-03 | 2010-10-27 | Merial, Inc. | Recombinant canine adenovirus 2 (cav2) containing exogenous dna |
ATE199022T1 (de) * | 1996-10-09 | 2001-02-15 | Akzo Nobel Nv | Europäische vakzinstämme des fortplanzungs- atmungs-syndromsvirus des sweins (prrsv) |
US6183752B1 (en) | 1997-02-05 | 2001-02-06 | Pasteur Merieux Serums Et Vaccins | Restenosis/atherosclerosis diagnosis, prophylaxis and therapy |
FR2781159B1 (fr) * | 1998-07-06 | 2000-10-06 | Merial Sas | Vaccin circovirus et parvovirus porcin |
US7078388B2 (en) * | 2000-01-21 | 2006-07-18 | Merial | DNA vaccines for farm animals, in particular bovines and porcines |
RU2269361C2 (ru) | 2004-03-25 | 2006-02-10 | Федеральное государственное учреждение "Федеральный центр охраны здоровья животных" (ФГУ ВНИИЗЖ) | Вакцина ассоциированная эмульсионная инактивированная против репродуктивно-респираторного синдрома и парвовирусной инфекции свиней |
PT2281829E (pt) | 2004-12-30 | 2015-02-18 | Boehringer Ingelheim Vetmed | Composições imunogénicas de pcv2 para utilização num método de prevenção de infecção de pcv2 |
US7833707B2 (en) | 2004-12-30 | 2010-11-16 | Boehringer Ingelheim Vetmedica, Inc. | Methods of overexpression and recovery of porcine circovirus type 2 ORF2 |
US7700285B1 (en) | 2005-12-29 | 2010-04-20 | Boehringer Ingelheim Vetmedica, Inc. | PCV2 immunogenic compositions and methods of producing such compositions |
CN109125721A (zh) | 2005-12-29 | 2019-01-04 | 贝林格尔.英格海姆维特梅迪卡有限公司 | Pcv2免疫原性组合物用于减轻猪临床症状的用途 |
AR078253A1 (es) | 2009-09-02 | 2011-10-26 | Boehringer Ingelheim Vetmed | Metodos para reducir la actividad antivirica en composiciones pcv-2 y composiciones pcv-2 con mejor inmunogenicidad |
WO2011075379A1 (en) * | 2009-12-18 | 2011-06-23 | Boehringer Ingelheim Vetmedica, Inc. | Multivalent vaccine against porcine teschovirus and other disease causing organisms in swine |
EP2542260B1 (en) | 2010-03-05 | 2016-03-02 | Intervet International B.V. | Recombinant Attenuated Parvovirus |
TWI508974B (zh) | 2010-12-22 | 2015-11-21 | Sbc Virbac Ltd | 豬第二型環狀病毒(Porcine Circovirus Type 2)、含彼之免疫組合物、檢測套組及其應用 |
BR122021013826B1 (pt) | 2011-02-17 | 2022-11-22 | Boehringer Ingelheim Vetmedica Gmbh | Composição de proteína, ácido nucleico isolado e vetor de expressão recombinante |
AR088028A1 (es) | 2011-08-15 | 2014-05-07 | Boehringer Ingelheim Vetmed | Proteinas h5, de h5n1 para un uso medicinal |
CN102488895A (zh) | 2011-12-30 | 2012-06-13 | 重庆大学 | 一种猪圆环病毒、猪细小病毒、猪繁殖与呼吸综合症病毒三联病毒样颗粒疫苗及其制备方法 |
CN102727881A (zh) * | 2012-07-04 | 2012-10-17 | 广东大华农动物保健品股份有限公司 | 高致病性猪繁殖与呼吸综合征jxa1-r株-猪细小病毒病二联活疫苗及其制备方法和应用 |
US20140170180A1 (en) | 2012-12-17 | 2014-06-19 | Boehringer Ingelheim Vetmedica, Inc. | Porcine parvovirus 5a, methods of use and vaccine |
US20140234354A1 (en) | 2013-02-15 | 2014-08-21 | Boehringer Ingelheim Vetmedica, Inc. | Porcine parvovirus 5b, methods of use and vaccine |
CN105246505A (zh) | 2013-04-30 | 2016-01-13 | 勃林格殷格翰动物保健公司 | PCV2a亚型(PCV2a)的ORF2蛋白用于交叉保护中的用途 |
CN104288760A (zh) | 2013-07-18 | 2015-01-21 | 普莱柯生物工程股份有限公司 | 一种疫苗组合物及其制备方法和应用 |
KR20160132494A (ko) | 2014-04-03 | 2016-11-18 | 베링거잉겔하임베트메디카인코퍼레이티드 | 돼지 유행성 설사 바이러스 백신 |
RS64144B1 (sr) * | 2016-11-03 | 2023-05-31 | Boehringer Ingelheim Vetmedica Gmbh | Vakcina protiv svinjskog parvovirusa i virusa reproduktivnog i respiratornog sindroma svinja i postupci njegove proizvodnje |
MY191490A (en) | 2016-11-03 | 2022-06-28 | Boehringer Ingelheim Vetmedica Gmbh | Vaccine against porcine parvovirus |
-
2017
- 2017-11-02 RS RS20230301A patent/RS64144B1/sr unknown
- 2017-11-02 MX MX2019005136A patent/MX2019005136A/es unknown
- 2017-11-02 WO PCT/EP2017/078020 patent/WO2018083156A1/en unknown
- 2017-11-02 EA EA201991041A patent/EA201991041A1/ru unknown
- 2017-11-02 FI FIEP17808328.3T patent/FI3534939T3/fi active
- 2017-11-02 JP JP2019522895A patent/JP6941171B2/ja active Active
- 2017-11-02 PL PL17808328.3T patent/PL3534939T3/pl unknown
- 2017-11-02 MY MYPI2019002230A patent/MY191895A/en unknown
- 2017-11-02 US US15/801,754 patent/US10660952B2/en active Active
- 2017-11-02 HU HUE17808328A patent/HUE061972T2/hu unknown
- 2017-11-02 PT PT178083283T patent/PT3534939T/pt unknown
- 2017-11-02 CA CA3042584A patent/CA3042584A1/en active Pending
- 2017-11-02 KR KR1020197015849A patent/KR20190080921A/ko active IP Right Grant
- 2017-11-02 BR BR112019009131A patent/BR112019009131A2/pt unknown
- 2017-11-02 ES ES17808328T patent/ES2942749T3/es active Active
- 2017-11-02 AU AU2017353380A patent/AU2017353380A1/en active Pending
- 2017-11-02 DK DK17808328.3T patent/DK3534939T3/da active
- 2017-11-02 TW TW106137854A patent/TWI788309B/zh active
- 2017-11-02 EP EP17808328.3A patent/EP3534939B1/en active Active
- 2017-11-02 CN CN201780064357.8A patent/CN109922825B/zh active Active
-
2019
- 2019-04-30 CL CL2019001200A patent/CL2019001200A1/es unknown
- 2019-05-02 MX MX2021002989A patent/MX2021002989A/es unknown
- 2019-05-03 PH PH12019500989A patent/PH12019500989A1/en unknown
-
2020
- 2020-05-20 US US16/879,471 patent/US11730806B2/en active Active
-
2021
- 2021-09-03 JP JP2021143679A patent/JP2022000031A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
TW201828982A (zh) | 2018-08-16 |
KR20190080921A (ko) | 2019-07-08 |
HUE061972T2 (hu) | 2024-02-28 |
EA201991041A1 (ru) | 2019-11-29 |
FI3534939T3 (fi) | 2023-05-15 |
CN109922825A (zh) | 2019-06-21 |
EP3534939A1 (en) | 2019-09-11 |
ES2942749T3 (es) | 2023-06-06 |
WO2018083156A1 (en) | 2018-05-11 |
AU2017353380A1 (en) | 2019-06-20 |
RS64144B1 (sr) | 2023-05-31 |
EP3534939B1 (en) | 2023-02-22 |
PL3534939T3 (pl) | 2023-06-12 |
MX2019005136A (es) | 2019-06-20 |
US20200345834A1 (en) | 2020-11-05 |
US20180147278A1 (en) | 2018-05-31 |
MX2021002989A (es) | 2021-05-14 |
US11730806B2 (en) | 2023-08-22 |
CN109922825B (zh) | 2024-01-12 |
CL2019001200A1 (es) | 2019-09-06 |
CA3042584A1 (en) | 2018-05-11 |
JP6941171B2 (ja) | 2021-09-29 |
US10660952B2 (en) | 2020-05-26 |
MY191895A (en) | 2022-07-18 |
PT3534939T (pt) | 2023-04-20 |
JP2020500843A (ja) | 2020-01-16 |
DK3534939T3 (da) | 2023-04-24 |
TWI788309B (zh) | 2023-01-01 |
PH12019500989A1 (en) | 2019-11-25 |
JP2022000031A (ja) | 2022-01-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112019009131A2 (pt) | vacina contra o parvovírus suíno, o vírus da síndrome respiratória e reprodutiva dos suínos e métodos de produção das mesmas | |
CL2018001053A1 (es) | Vacuna contra el virus sincicial respiratorio | |
CL2018001056A1 (es) | Vacuna contra el virus herpes simplex | |
CO2017011851A2 (es) | Compuestos novedosos | |
PE20210451A1 (es) | Oligonucleotidos para inducir la expresion paterna de ube3a | |
BR112017005917A2 (pt) | processos e composições para indução de imunidade protetora contra infecção com o vírus da imunodeficiência humana | |
CO2020001927A2 (es) | Método de producción de composiciones farmacéuticas que comprende el virus chikungunya inmunogénico chikv-delta5nsp3 | |
PH12017501370A1 (en) | Bivalent swine influenza virus vaccine | |
BR112019014963A8 (pt) | Compostos-bis para dispositivos opticamente ativos | |
UY32457A (es) | Vacuna del virus del dengue inactivado | |
BR112016024096A2 (pt) | novo bacteriófago e composição compreendendo o mesmo | |
BR112016023613A2 (pt) | novo bacteriófago e composição compreendendo o mesmo | |
BR112018010503A2 (pt) | ovo de ave, método para replicar um vírus, vírus, método para produzir uma composição de vacina, composição de vacina, ave transgênica, e método para produzir uma ave | |
BR112018014590A2 (pt) | formulações/composições compreendendo um inibidor de btk | |
EA201691754A1 (ru) | Рекомбинантный микроорганизм, экспрессирующий аналог авермектина, и его применение | |
BR112017004197A2 (pt) | composições de vacina contra doenças do vírus da dengue | |
BR112018014540A2 (pt) | formulações/composições compreendendo inibidor de btk | |
BR112019021300A8 (pt) | Composições de fragrâncias e produtos com efeitos de melhora do humor | |
PE20170185A1 (es) | Composiciones farmaceuticas para tratar enfermedades infecciosas | |
BR112018004400A2 (pt) | composições de vacina vlp estabilizadas | |
BR112018006870A2 (pt) | nanopartículas terapêuticas que compreendem um agente terapêutico e métodos para a produção e o uso das mesmas | |
BR112017023448A2 (pt) | composições anti-fitopatogênicas | |
BR112018074910A2 (pt) | composição imunológica, e, método de indução de uma resposta imunológica contra o vírus da influenza equina em um sujeito | |
BR112018076734A2 (pt) | compostos heterocíclicos anti-infecciosos e usos dos mesmos | |
CO2017003994A2 (es) | Derivados de nucleósidos sustituidos con 4’-vinilo como inhibidores de la replicación del arn del virus respiratorio sincitial |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
B06W | Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette] |